Healthcare · Pharmaceuticals

SMS Pharmaceuticals Ltd (SMSPHARMA)

₹399.15

Mkt cap
₹3,727 Cr
P/E ratio
36.40
P/B
4.76
Div yield
0.10%
ROE
14.30%
ROCE
13.30%
EPS (TTM)
₹10.97
Book value
₹84
52W range
233–438
Sector
Healthcare

Price history

Previous close

SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates. [1]

NSE SMSPHARMABSE 532815
Health check
Constructive
ValuationFair
ProfitabilityAverage
GrowthModerate
TechnicalsBullish
52-week range
−8.93% from high
₹399
₹233+71.18% from low₹438
Current
₹399.15
Prev close
₹397.80
Day
+0.34%
Price performance
1D
+0.34%
1W
+8.39%
1M
+7.33%
3M
+4.61%
6M
+3.39%
1Y
+70.10%
YTD
+22.34%

Financials

Revenue, profit & margin
P/E ratio
36.4×
SMSPHARMA is 4% above the sector median of 35.1×
SMSPHARMA36.4×
Sector median35.1×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales135167161246164197173248196242210238207
Expenses109139132212131165140207157194167198166
Operating Profit26282934343133413948444041
OPM %19%17%18%14%20%16%19%16%20%20%21%17%20%
Other Income1112112111432
Interest6666554566656
Depreciation888889991010101010
Profit before tax13151722222022292434312727
Tax %31%21%26%26%25%29%24%30%23%26%26%23%26%
Net Profit9121117161418202025233321
EPS in Rs1.101.381.362.041.951.662.152.292.312.702.513.492.23
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −2.77% · closed higher next day 0 of last 1
 Q1FY27
Broadcast31 Jul '26
Earnings day−2.77%
+1 day−2.78%
+5 days−0.53%
+15 days−5.30%
+30 days
FilingXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Jun 2026
68.07%Promoter
Promoters68.07%
FIIs0.65%0.34
DIIs2.83%0.19
Public28.45%0.15
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
SUNPHARMA₹1,895.0035.994,54,6740.84%2,901+5.95%15,300+10.46%20.53%
DIVISLAB₹9,315.0083.002,47,2840.32%902+65.50%3,080+27.80%21.97%
TORNTPHARM₹4,914.0083.771,86,9130.77%566+5.79%4,921+54.85%15.19%
ZYDUSLIFE₹1,156.9023.701,15,4010.09%990−35.09%8,017+21.96%21.14%
CIPLA₹1,395.0031.491,12,6960.93%786−39.19%7,119+2.33%15.49%
LAURUSLABS₹1,876.7092.741,01,4000.11%362+125.49%2,026+29.10%17.76%
LUPIN₹2,105.0016.1796,2540.86%1,417+16.08%8,277+32.04%29.93%
SMSPHARMA₹397.9536.403,7270.10%21+2.05%207+5.56%13.30%
Median: 159 Co.₹423.0035.072,2820.08%13+29.60%162+18.62%15.04%

Filings